A comprehensive view of Novo Nordisk A/S. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Patent Issued for Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS6) expression (USPTO 11952574)
Published: April 26, 2024 by Disease Prevention Daily
Morgan Stanley: Tobacco industry has reason to fret about GLP-1 drugs like Ozempic; survey finds 40% smoked cigarettes at least weekly before starting drug, and number fell to 24% after treatment, while weekly e-cigarette usage fell from 30% to 16%
Published: April 24, 2024 by Gizmodo
Novo Nordisk's acquisition of Cardior Pharmaceuticals gets approval from Germany's Federal Cartel Office; Novo Nordisk to buy the company for US$1.09B, which is expected to expand its pipeline of heart drugs
Published: April 18, 2024 by SeeNews Deals
GlobalData: Eli Lilly set to reshape pharmaceutical landscape with obesity and Alzheimer's treatments, Mounjaro and donanemab; both drugs poised to beat market expectations, with Mounjaro's sales poised to reach US$34B in 2029, more than double Wegovy's
Published: April 17, 2024 by GlobalData Plc
Leaders from Genentech, Bayer, Novo Nordisk, Takeda and others to be keynote speakers at Veeva Commercial Summit; speakers to discuss strategies for effective commercialization and customer engagement
Published: April 17, 2024 by PR Newswire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count